Garcia-Foncillas J - Search Results

1

Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis.

Rosmarin D, Palles C, Church D, Domingo E, Jones A, Johnstone E, Wang H, Love S, Julier P, Scudder C, Nicholson G, Gonzalez-Neira A, Martin M, Sargent D, Green E, McLeod H, Zanger UM, Schwab M, Braun M, Seymour M, Thompson L, Lacas B, Boige V, Ribelles N, Afzal S, Enghusen H, Jensen SA, Etienne-Grimaldi MC, Milano G, Wadelius M, Glimelius B, Garmo H, Gusella M, Lecomte T, Laurent-Puig P, Martinez-Balibrea E, Sharma R, Garcia-Foncillas J, Kleibl Z, Morel A, Pignon JP, Midgley R, Kerr D, Tomlinson I. Rosmarin D, et al. J Clin Oncol. 2014 Apr 1;32(10):1031-9. doi: 10.1200/JCO.2013.51.1857. Epub 2014 Mar 3. J Clin Oncol. 2014. PMID: 24590654 Free PMC article. Review.

2

Front-line paclitaxel/cisplatin-based chemotherapy in brain metastases from non-small-cell lung cancer.

Cortes J, Rodriguez J, Aramendia JM, Salgado E, Gurpide A, Garcia-Foncillas J, Aristu JJ, Claver A, Bosch A, Lopez-Picazo JM, Martin-Algarra S, Brugarolas A, Calvo E. Cortes J, et al. Oncology. 2003;64(1):28-35. doi: 10.1159/000066520. Oncology. 2003. PMID: 12457029

3

Paclitaxel, cisplatin, and vinorelbine combination chemotherapy in metastatic non-small-cell lung cancer.

Cortes J, Rodriguez J, Calvo E, Gurpide A, Garcia-Foncillas J, Salgado E, Aramendia JM, Lopez-Picazo JM, Hernandez B, Hidalgo R, Aristu JJ, Brugarolas A, Martin-Algarra S. Cortes J, et al. Am J Clin Oncol. 2004 Jun;27(3):299-303. doi: 10.1097/01.coc.0000071460.56153.f8. Am J Clin Oncol. 2004. PMID: 15170152 Clinical Trial.

4

Polymorphisms in the thymidylate synthase and dihydropyrimidine dehydrogenase genes predict response and toxicity to capecitabine-raltitrexed in colorectal cancer.

Salgado J, Zabalegui N, Gil C, Monreal I, Rodríguez J, García-Foncillas J. Salgado J, et al. Oncol Rep. 2007 Feb;17(2):325-8. Oncol Rep. 2007. PMID: 17203168

5

Pharmacogenomic approach for the identification of novel determinants of acquired resistance to oxaliplatin in colorectal cancer.

Martinez-Cardús A, Martinez-Balibrea E, Bandrés E, Malumbres R, Ginés A, Manzano JL, Taron M, Garcia-Foncillas J, Abad A. Martinez-Cardús A, et al. Mol Cancer Ther. 2009 Jan;8(1):194-202. doi: 10.1158/1535-7163.MCT-08-0659. Mol Cancer Ther. 2009. PMID: 19139129

6

Progress in metastatic colorectal cancer: growing role of cetuximab to optimize clinical outcome.

García-Foncillas J, Díaz-Rubio E. García-Foncillas J, et al. Clin Transl Oncol. 2010 Aug;12(8):533-42. doi: 10.1007/s12094-010-0551-3. Clin Transl Oncol. 2010. PMID: 20709651 Review.

7

Chemotherapy-induced growth hormone deficiency in children with cancer.

Román J, Villaizán CJ, García-Foncillas J, Azcona C, Salvador J, Sierrasesúmaga L. Román J, et al. Med Pediatr Oncol. 1995 Aug;25(2):90-5. doi: 10.1002/mpo.2950250208. Med Pediatr Oncol. 1995. PMID: 7603406

8

Phase II evaluation of doxorubicin, ifosfamide, and dacarbazine plus amphotericin B in the treatment of metastatic soft tissue sarcomas. A pilot study.

González-Manzano R, Vieitez JM, Tangco E, Fernandez de Alava E, Herranz P, Garcia-Foncillas J. González-Manzano R, et al. Am J Clin Oncol. 1993 Aug;16(4):332-7. doi: 10.1097/00000421-199308000-00012. Am J Clin Oncol. 1993. PMID: 8328412 Clinical Trial.

9

Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer.

Jurado M, Martínez-Monge R, García-Foncillas J, Azinovic I, Aristu J, López-García G, Brugarolas A. Jurado M, et al. Gynecol Oncol. 1999 Jul;74(1):30-7. doi: 10.1006/gyno.1999.5424. Gynecol Oncol. 1999. PMID: 10385548 Clinical Trial.

10

Polymorphisms of the repeated sequences in the enhancer region of the thymidylate synthase gene promoter may predict downstaging after preoperative chemoradiation in rectal cancer.

Villafranca E, Okruzhnov Y, Dominguez MA, García-Foncillas J, Azinovic I, Martínez E, Illarramendi JJ, Arias F, Martínez Monge R, Salgado E, Angeletti S, Brugarolas A. Villafranca E, et al. J Clin Oncol. 2001 Mar 15;19(6):1779-86. doi: 10.1200/JCO.2001.19.6.1779. J Clin Oncol. 2001. PMID: 11251009

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

314 results

Search Page